Novel small RNA expression libraries uncover hsa-miR-30b and hsa-miR-30c as important factors in anoikis resistance

RNA

Volumn 19, Issue 12, 2013, Pages 1711-1725

  Moreno Mateos, Miguel A ^a,d   Barraǵan, Verónica ^a,d   Torres, Belén ^a   Rodríguez Mateo, Cristina ^a   Méndez Vidal, Cristina ^a   Berezikov, Eugene ^b   Mudduluru, Giridhar ^c   Allgayer, Heike ^c   Pintor Toro, José A ^a  

^a CABIMER Andalusian Center for Molecular Biology and Regenerative Medicine CSIC University of Seville UPO   (Spain)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anoikis; Functional screens; Libraries; MiR 30b c; Small RNAs

Indexed keywords

CASPASE 3; DNA; DNA DIRECTED RNA POLYMERASE III; MICRORNA; MICRORNA 30B; MICRORNA 30C; RNA; UNCLASSIFIED DRUG;

ACINAR CELL; ANOIKIS; ARTICLE; BREAST CANCER; CANCER CELL; CELL DEATH; CELL STRAIN HCT116; CELL STRAIN HEK293; CELL STRUCTURE; COLORECTAL CARCINOMA; DOWN REGULATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; MOLECULAR LIBRARY; MORPHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

ANOIKIS; FUNCTIONAL SCREENS; LIBRARIES; MIR-30B/C; SMALL RNAS;

3' UNTRANSLATED REGIONS; ANOIKIS; BASE SEQUENCE; BINDING SITES; CASPASE 3; CELL CULTURE TECHNIQUES; CELL SHAPE; ENZYME REPRESSION; FEMALE; GENE EXPRESSION; GENE LIBRARY; HCT116 CELLS; HEK293 CELLS; HUMANS; MAMMARY GLANDS, HUMAN; MICRORNAS; MORPHOGENESIS; RNA INTERFERENCE;

EID: 84888396454     PISSN: 13558382     EISSN: 14699001     Source Type: Journal    
DOI: 10.1261/rna.039461.113     Document Type: Article

References (55)

1. Alfano D, Iaccarino I, Stoppelli MP. 2006. Urokinase signaling through its receptor protects against anoikis by increasing BCL-xL expression levels. J Biol Chem 281: 17758-17767.
2. Asangani IA, Rasheed SA, Nikolova DA, Leupold JH, Colburn NH, Post S, Allgayer H. 2008. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27: 2128-2136.
3. Baraniskin A, Birkenkamp-Demtroder K, Maghnouj A, Zollner H, Munding J, Klein-Scory S, Reinacher-Schick A, Schwarte-Waldhoff I, Schmiegel W, Hahn SA. 2012. MiR-30a-5p suppresses tumor growth in colon carcinoma by targeting DTL. Carcinogenesis 33: 732-739.
4. Bartel DP. 2009. MicroRNAs: Target recognition and regulatory functions. Cell 136: 215-233.
5. Berezikov E. 2011. Evolution of microRNA diversity and regulation in animals. Nat Rev 12: 846-860.
6. Berezikov E, Liu N, Flynt AS, Hodges E, Rooks M, Hannon GJ, Lai EC. 2010. Evolutionary flux of canonical microRNAs and mirtrons in Drosophila. Nat Genet 42: 6-9; author reply 9-10.
7. Betel D, Wilson M, Gabow A, Marks DS, Sander C. 2008. The microRNA.org resource: Targets and expression. Nucleic Acids Res 36: D149 -D153.
8. Brennecke J, Stark A, Russell RB, Cohen SM. 2005. Principles of microRNA-target recognition. PLoS Biol 3: e85.
9. Bueno MJ, Perez de Castro I, Malumbres M. 2008. Control of cell proliferation pathways by microRNAs. Cell Cycle 7: 3143-3148.
10. ChengCW, WangHW, Chang CW, ChuHW, Chen CY, Yu JC, Chao JI, Liu HF, Ding SL, Shen CY. 2012. MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer. Breast Cancer Res Treat 134: 1081-1093.
11. Chiarugi P, Giannoni E. 2008. Anoikis: A necessary death program for anchorage-dependent cells. Biochem Pharmacol 76: 1352-1364.
12. Cummins JM, He Y, Leary RJ, Pagliarini R, Diaz LA Jr, Sjoblom T, Barad O, Bentwich Z, Szafranska AE, Labourier E, et al. 2006. The colorectal microRNAome. Proc Natl Acad Sci 103: 3687-3692.
13. Debnath J, Brugge JS. 2005. Modelling glandular epithelial cancers in three-dimensional cultures. Nat Rev Cancer 5: 675-688.
14. Devarajan E, Sahin AA, Chen JS, Krishnamurthy RR, Aggarwal N, Brun AM, Sapino A, Zhang F, Sharma D, Yang XH, et al. 2002. Down-regulation of caspase 3 in breast cancer: A possible mechanism for chemoresistance. Oncogene 21: 8843-8851.
15. Dueck A, Ziegler C, Eichner A, Berezikov E, Meister G. 2012. microRNAs associated with the different human Argonaute proteins. Nucleic Acids Res 40: 9850-9862.
16. Fang J, Song XW, Tian J, Chen HY, Li DF, Wang JF, Ren AJ, Yuan WJ, Lin L. 2011. Overexpression of microRNA-378 attenuates ischemia-induced apoptosis by inhibiting caspase-3 expression in cardiac myocytes. Apoptosis 17: 410-423.
17. Friedman RC, Farh KK, Burge CB, Bartel DP. 2009. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19: 92-105.
18. Fukazawa H, Noguchi K, Masumi A, Murakami Y, Uehara Y. 2004. BimEL is an important determinant for induction of anoikis sensitivity by mitogen-activated protein/extracellular signal-regulated kinase kinase inhibitors. Mol Cancer Ther 3: 1281-1288.
19. Garofalo M, Romano G, Di Leva G, Nuovo G, Jeon YJ, Ngankeu A, Sun J, Lovat F, Alder H, Condorelli G, et al. 2011. EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers. Nat Med 18: 74-82.
20. Gaziel-Sovran A, Segura MF, Di Micco R, Collins MK, Hanniford D, Vega-Saenz de Miera E, Rakus JF, Dankert JF, Shang S, Kerbel RS, et al. 2011. miR-30b/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasis. Cancer Cell 20: 104-118.
21. Gramantieri L, Fornari F, Ferracin M, Veronese A, Sabbioni S, Calin GA, Grazi GL, Croce CM, Bolondi L, Negrini M. 2009. MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality. Clin Cancer Res 15: 5073-5081.
22. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP. 2007. MicroRNA targeting specificity in mammals: Determinants beyond seed pairing. Mol Cell 27: 91-105.
23. Hafner M, Renwick N, Brown M, Mihailovic A, Holoch D, Lin C, Pena JT, Nusbaum JD, Morozov P, Ludwig J, et al. 2011. RNA-ligase-dependent biases in miRNA representation in deep-sequenced small RNA cDNA libraries. RNA 17: 1697-1712.
24. Hanahan D, Weinberg RA. 2011. Hallmarks of cancer: The next generation. Cell 144: 646-674.
25. Howe EN, Cochrane DR, Richer JK. 2011. Targets of miR-200c mediate suppression of cell motility and anoikis resistance. Breast Cancer Res 13: R45.
26. Inui M, Martello G, Piccolo S. 2010. MicroRNA control of signal transduction. Nat Rev Mol Cell Biol 11: 252-263.
27. Izumiya M, Tsuchiya N, Okamoto K, Nakagama H. 2011. Systematic exploration of cancer-associated microRNA through functional screening assays. Cancer Sci 102: 1615-1621.
28. Kim VN, Han J, Siomi MC. 2009. Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol 10: 126-139.
29. Kugler W, Buchholz F, Kohler F, Eibl H, Lakomek M, Erdlenbruch B. 2005. Downregulation of Apaf-1 and caspase-3 by RNA interference in human glioma cells: Consequences for erucylphosphocholine-induced apoptosis. Apoptosis 10: 1163-1174.
30. Kumar MS, Lu J, Mercer KL, Golub TR, Jacks T. 2007. Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet 39: 673-677.
31. Kumarswamy R, Mudduluru G, Ceppi P, Muppala S, Kozlowski M, Niklinski J, Papotti M, Allgayer H. 2012. MicroRNA-30a inhibits epithelial-to-mesenchymal transition by targeting Snai1 and is downregulated in non-small cell lung cancer. Int J Cancer 130: 2044-2053.
32. Li N, Kaur S, Greshock J, Lassus H, Zhong X, Wang Y, Leminen A, Shao Z, Hu X, Liang S, et al. 2012a. A combined array-based comparative genomic hybridization and functional library screening approach identifies mir-30d as an oncomir in cancer. Cancer Res 72: 154-164.
33. Li Z, Ender C, Meister G, Moore PS, Chang Y, John B. 2012b. Extensive terminal and asymmetric processing of small RNAs from rRNAs, snoRNAs, snRNAs, and tRNAs. Nucleic Acids Res 40: 6787-6799.
34. Lima RT, Busacca S, Almeida GM, Gaudino G, Fennell DA, Vasconcelos MH. 2011. MicroRNA regulation of core apoptosis pathways in cancer. Eur J Cancer 47: 163-174.
35. Lu Y, Ryan SL, Elliott DJ, Bignell GR, Futreal PA, Ellison DW, Bailey S, Clifford SC. 2009. Amplification and overexpression of Hsa-miR-30b, Hsa-miR-30d and KHDRBS3 at 8q24.22-q24.23 in medulloblastoma. PLoS One 4: e6159.
36. Maragkakis M, Reczko M, Simossis VA, Alexiou P, Papadopoulos GL, Dalamagas T, Giannopoulos G, Goumas G, Koukis E, Kourtis K, et al. 2009. DIANA-microT web server: Elucidating microRNA functions through target prediction. Nucleic Acids Res 37: W273-W276.
37. Mazzon M, Jones M, Davidson A, Chain B, Jacobs M. 2009. Dengue virus NS5 inhibits interferon-á signaling by blocking signal transducer and activator of transcription 2 phosphorylation. J Infect Dis 200: 1261-1270.
38. Ovcharenko D, Kelnar K, Johnson C, Leng N, Brown D. 2007. Genomescale microRNA and small interfering RNA screens identify small RNA modulators of TRAIL-induced apoptosis pathway. Cancer Res 67: 10782-10788.
39. Penna E, Orso F, Cimino D, Tenaglia E, Lembo A, Quaglino E, Poliseno L, Haimovic A, Osella-Abate S, De Pitta C, et al. 2011. microRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C. EMBO J 30: 1990-2007.
40. Quintavalle C, Donnarumma E, Iaboni M, Roscigno G, Garofalo M, Romano G, Fiore D, De Marinis P, Croce CM, Condorelli G. 2013. Effect of miR-21 and miR-30b/c on TRAIL-induced apoptosis in glioma cells. Oncogene 32: 4001-4008.
41. Rother S, Meister G. 2011. Small RNAs derived from longer non-coding RNAs. Biochimie 93: 1905-1915.
42. Strasser A, Cory S, Adams JM. 2011. Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases. EMBO J 30: 3667-3683.
43. Suffert G, Malterer G, Hausser J, Viiliainen J, Fender A, Contrant M, Ivacevic T, Benes V, Gros F, Voinnet O, et al. 2011. Kaposi's sarcoma herpesvirus microRNAs target caspase 3 and regulate apoptosis. PLoS Pathog 7: e1002405.
44. Taft RJ, Pang KC, Mercer TR, Dinger M, Mattick JS. 2010. Non-coding RNAs: Regulators of disease. J Pathol 220: 126-139.
45. Toedling J, Servant N, Ciaudo C, Farinelli L, Voinnet O, Heard E, Barillot E. 2012. Deep-sequencing protocols influence the results obtained in small-RNA sequencing. PLoS One 7: e32724.
46. Tsang WP, Kwok TT. 2008. Let-7a microRNA suppresses therapeuticsinduced cancer cell death by targeting caspase-3. Apoptosis 13: 1215-1222.
47. Volinia S, Galasso M, Costinean S, Tagliavini L, Gamberoni G, Drusco A, Marchesini J, Mascellani N, Sana ME, Abu Jarour R, et al. 2010. Reprogramming of miRNA networks in cancer and leukemia. Genome Res 20: 589-599.
48. Wang Y, Baskerville S, Shenoy A, Babiarz JE, Baehner L, Blelloch R. 2008. Embryonic stem cell-specific microRNAs regulate the G1-S transition and promote rapid proliferation. Nat Genet 40: 1478-1483.
49. Wang Y, Rathinam R, Walch A, Alahari SK. 2009. ST14 (suppression of tumorigenicity 14) gene is a target for miR-27b, and the inhibitory effect of ST14 on cell growth is independent of miR-27b regulation. J Biol Chem 284: 23094-23106.
50. Wang HQ, Yu XD, Liu ZH, Cheng X, Samartzis D, Jia LT, Wu SX, Huang J, Chen J, Luo ZJ. 2011. Deregulated miR-155 promotes Fas-mediated apoptosis in human intervertebral disc degeneration by targeting FADD and caspase-3. J Pathol 225: 232-242.
51. Winter RN, Kramer A, Borkowski A, Kyprianou N. 2001. Loss of caspase-1 and caspase-3 protein expression in human prostate cancer. Cancer Res 61: 1227-1232.
52. L plays a survival role and regulates morphogenesis in breast epithelial cells. Biochim Biophys Acta 1813: 168-178.
53. Zhang N, Wang X, Huo Q, Sun M, Cai C, Liu Z, Hu G, Yang Q. 2013. MicroRNA-30a suppresses breast tumor growth and metastasis by targeting metadherin. Oncogene doi: 10.1038/onc.2013.286.
54. Zheng L, Liu J, Batalov S, Zhou D, Orth A, Ding S, Schultz PG. 2004. An approach to genomewide screens of expressed small interfering RNAs in mammalian cells. Proc Natl Acad Sci 101: 135-140.
55. Zhuang F, Fuchs RT, Robb GB. 2012. Small RNA expression profiling by high-throughput sequencing: Implications of enzymatic manipulation. J Nucleic Acids 2012: 360358.